ENTITY
Bio FD&C

Bio FD&C (251120 KS)

2
Analysis
Health Care • South Korea
Bio FD&C Co Ltd researches and develops plant cell technology. The Company develops plant derived recombinant growth factors, phytopeptides, rose cell lines and other plant cell culture technologies. Bio FD&C also produces stem cell promotor, urination improver, incontinence treatment health supplement and anti-aging materials.
more
bullish•KMF
•07 Oct 2026 05:10

KMF IPO Preview

KMF is getting ready to complete its IPO on the KOSDAQ market in November. Total revenue and net income increased by 259% from 2023 to 2025....

Logo
90 Views
Share
bullish•Bio FD&C
•04 Jan 2022 19:37

Bio FD&C IPO Preview

Bio FD&C develops anti-aging materials with plant cell line design and plant cell culture technology. Bio FD&C has a gray market price of 90,000...

Logo
347 Views
Share
x